SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-24-026847
Filing Date
2024-08-14
Accepted
2024-08-14 16:39:03
Documents
71
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q nrxp20240630_10q.htm   iXBRL 10-Q 1411762
2 EXHIBIT 31.1 ex_694551.htm EX-31.1 11990
3 EXHIBIT 31.2 ex_694552.htm EX-31.2 11755
4 EXHIBIT 32.1 ex_694553.htm EX-32.1 5354
5 EXHIBIT 32.2 ex_694554.htm EX-32.2 5350
11 nrxp-20240331x10q001.jpg GRAPHIC 72207
12 nrxp-20240331x10q002.jpg GRAPHIC 48140
  Complete submission text file 0001437749-24-026847.txt   7528457

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA nrxp-20240630.xsd EX-101.SCH 61289
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nrxp-20240630_cal.xml EX-101.CAL 30034
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nrxp-20240630_def.xml EX-101.DEF 482412
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE nrxp-20240630_lab.xml EX-101.LAB 369417
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nrxp-20240630_pre.xml EX-101.PRE 502801
74 EXTRACTED XBRL INSTANCE DOCUMENT nrxp20240630_10q_htm.xml XML 1104533
Mailing Address 1201 ORANGE STREET SUITE 600 WILMINGTON DE 19801
Business Address 1201 ORANGE STREET SUITE 600 WILMINGTON DE 19801 484-254-6134
NRX Pharmaceuticals, Inc. (Filer) CIK: 0001719406 (see all company filings)

IRS No.: 822844431 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38302 | Film No.: 241208863
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)